Pages that link to "Q53710173"
Jump to navigation
Jump to search
The following pages link to Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells. (Q53710173):
Displaying 8 items.
- Disrupted regulatory T cell homeostasis in inflammatory bowel diseases (Q26774590) (← links)
- CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis (Q33695285) (← links)
- Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. (Q38125275) (← links)
- T regulatory cells in childhood arthritis--novel insights (Q38167815) (← links)
- Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual. (Q40506121) (← links)
- FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents (Q41919734) (← links)
- Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis (Q50955712) (← links)
- Differential effects of decoy receptor- and antibody-mediated tumour necrosis factor blockage on FoxP3 expression in responsive arthritis patients (Q56897523) (← links)